- Home
- INMB vs OPFI Comparison
INMB vs OPFI Comparison
Compare INMB & OPFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INMB
- OPFI
- Stock Information
- Founded
- INMB 2015
- OPFI 2009
- Country
- INMB United States
- OPFI United States
- Employees
- INMB N/A
- OPFI N/A
- Industry
- INMB Biotechnology: Pharmaceutical Preparations
- OPFI Finance: Consumer Services
- Sector
- INMB Health Care
- OPFI Finance
- Exchange
- INMB Nasdaq
- OPFI Nasdaq
- Market Cap
- INMB 176.5M
- OPFI 205.2M
- IPO Year
- INMB 2019
- OPFI N/A
- Fundamental
- Price
- INMB $7.32
- OPFI $8.30
- Analyst Decision
- INMB Strong Buy
- OPFI Buy
- Analyst Count
- INMB 3
- OPFI 2
- Target Price
- INMB $24.33
- OPFI $7.50
- AVG Volume (30 Days)
- INMB 272.9K
- OPFI 1.1M
- Earning Date
- INMB 05-08-2025
- OPFI 05-07-2025
- Dividend Yield
- INMB N/A
- OPFI 3.03%
- EPS Growth
- INMB N/A
- OPFI N/A
- EPS
- INMB N/A
- OPFI 0.36
- Revenue
- INMB $14,000.00
- OPFI $276,770,000.00
- Revenue This Year
- INMB N/A
- OPFI $112.50
- Revenue Next Year
- INMB N/A
- OPFI $7.84
- P/E Ratio
- INMB N/A
- OPFI $23.06
- Revenue Growth
- INMB N/A
- OPFI 22.23
- 52 Week Low
- INMB $4.32
- OPFI $2.56
- 52 Week High
- INMB $12.72
- OPFI $17.73
- Technical
- Relative Strength Index (RSI)
- INMB 46.72
- OPFI 40.65
- Support Level
- INMB $7.14
- OPFI $8.00
- Resistance Level
- INMB $7.78
- OPFI $8.74
- Average True Range (ATR)
- INMB 0.71
- OPFI 0.61
- MACD
- INMB 0.00
- OPFI 0.01
- Stochastic Oscillator
- INMB 54.59
- OPFI 32.76
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.
About OPFI OppFi Inc.
OppFi Inc is a tech-enabled, mission-driven specialty finance platform that broadens the reach of community banks to extend credit access to everyday Americans. It recognizes revenue through finance charges on installment and SalaryTap contracts based on the interest method.